Annie Yoshiyama
Comptroller/Controller/Auditor chez ALLOGENE THERAPEUTICS, INC.
Fortune : 254 395 $ au 31/05/2024
Profil
Annie Yoshiyama is currently the Chief Accounting Officer, Controller & SVP at Allogene Therapeutics, Inc. She previously worked as the Chief Accounting Officer & Vice President-Finance at Tricida, Inc. from 2020 to 2023.
Prior to that, she was employed at Dolby Laboratories, Inc. as a Senior Financial Reporting from 2008 to 2018.
Annie also served as the Vice President-Finance & Controller at AN2 Therapeutics, Inc. from 2023 to 2024.
She completed her undergraduate and graduate degrees at the University of Southern California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2024 | 101 758 ( 0,05% ) | 254 395 $ | 31/05/2024 |
Postes actifs de Annie Yoshiyama
| Sociétés | Poste | Début |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05/06/2024 |
Anciens postes connus de Annie Yoshiyama
| Sociétés | Poste | Fin |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/03/2024 |
| TRICIDA, INC. | Comptroller/Controller/Auditor | 01/09/2023 |
| DOLBY LABORATORIES, INC. | Corporate Officer/Principal | 01/06/2018 |
Formation de Annie Yoshiyama
| University of Southern California | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TRICIDA, INC. | Health Technology |
| DOLBY LABORATORIES, INC. | Technology Services |
| AN2 THERAPEUTICS, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
